Form 4: Maze Therapeutics President Sells Shares
Insider Transaction (Form 4)
Harold Bernstein, President, R&D & CMO of Maze Therapeutics, Inc., sold 10,295 shares of common stock on September 2, 2026.
Summary
- Open-market sale: disposed of 4,481 Common Stock at $26.38 ($118,191) on September 2, 2026; holds 15,519 after (Direct).
- Open-market sale: disposed of 625 Common Stock at $27.12 ($16,951) on September 2, 2026; holds 14,894 after (Direct).
- Open-market sale: disposed of 5,130 Common Stock at $26.01 ($133,448) on September 3, 2026; holds 9,764 after (Direct).
- Open-market sale: disposed of 59 Common Stock at $25.78 ($1,521) on September 3, 2026; holds 9,705 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $270,111 of stock on the open market.
Insider Transactions
Harold Bernstein — Officer (President, R&D & CMO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-02 | Open-market sale | Common Stock | 4,481 | $26 | $118.2K | 15,519 |
| 2026-09-02 | Open-market sale | Common Stock | 625 | $27 | $17.0K | 14,894 |
| 2026-09-03 | Open-market sale | Common Stock | 5,130 | $26 | $133.4K | 9,764 |
| 2026-09-03 | Open-market sale | Common Stock | 59 | $26 | $1.5K | 9,705 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-02 | Open-market sale (4,481 shares) |
| 2026-09-02 | Open-market sale (625 shares) |
| 2026-09-03 | Open-market sale (5,130 shares) |
| 2026-09-03 | Open-market sale (59 shares) |
Keywords
insider transaction, Form 4, MAZE, Maze Therapeutics, Inc., bearish, Harold Bernstein
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.